Sign in
NXEN Stock Price, Chart, Stats & News
Nexien BioPharma, Inc.
Save
Nexien BioPharma, Inc. (NXEN) does not currently pay a dividend.
7,077
Market cap
–
Current P/E
–
Forward P/E
NXEN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical and clinical development paths to address a variety of diseases, medical conditions, and disorders. It adopted its current name in September 2018, having previously operated as Intiva BioPharma Inc.
Similar securities
Based on sector and market capitalization
Report issue